144 related articles for article (PubMed ID: 16299723)
21. Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women.
Corcoran A; Mahon BP; McParland P; Davoren A; Doyle S
J Med Virol; 2003 Jul; 70(3):475-80. PubMed ID: 12767014
[TBL] [Abstract][Full Text] [Related]
22. T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19.
Franssila R; Hokynar K; Hedman K
J Infect Dis; 2001 Mar; 183(5):805-9. PubMed ID: 11181158
[TBL] [Abstract][Full Text] [Related]
23. [Persistent parvovirus B19 infection in a patient with AIDS].
García-Tapia AM; Fernández C; Bascuñana A
Enferm Infecc Microbiol Clin; 1993 Feb; 11(2):107-8. PubMed ID: 8386943
[No Abstract] [Full Text] [Related]
24. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome.
Kerr JR; Cunniffe VS; Kelleher P; Bernstein RM; Bruce IN
Clin Infect Dis; 2003 May; 36(9):e100-6. PubMed ID: 12715326
[TBL] [Abstract][Full Text] [Related]
25. [Thrombocytopenia caused by Parvovirus B19 infection in a child with acute lymphatic leukemia].
Heegaard ED; Kerndrup GB; Carlsen NT; Schmiegelow K; Hornsleth AK
Ugeskr Laeger; 1999 Nov; 161(47):6501-2. PubMed ID: 10778359
[TBL] [Abstract][Full Text] [Related]
26. Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis.
Mehraein Y; Lennerz C; Ehlhardt S; Venzke T; Ojak A; Remberger K; Zang KD
Mod Pathol; 2003 Aug; 16(8):811-7. PubMed ID: 12920226
[TBL] [Abstract][Full Text] [Related]
27. Chronic human parvovirus B19 infection associated with interstitial lung disease.
Klar A; Halamish A; Shoseyov D; Cassinotti P; Siegl G; Springer C; Shazberg G; Hurvitz H
Isr Med Assoc J; 2002 Oct; 4(10):825-6. PubMed ID: 12389353
[No Abstract] [Full Text] [Related]
28. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors.
Manaresi E; Gallinella G; Morselli Labate AM; Zucchelli P; Zaccarelli D; Ambretti S; Delbarba S; Zerbini M; Musiani M
Epidemiol Infect; 2004 Oct; 132(5):857-62. PubMed ID: 15473148
[TBL] [Abstract][Full Text] [Related]
29. An assay for parvovirus B19 neutralizing antibodies based on human hepatocarcinoma cell lines.
Caillet-Fauquet P; Di Giambattista M; Draps ML; Hougardy V; de Launoit Y; Laub R
Transfusion; 2004 Sep; 44(9):1340-3. PubMed ID: 15318858
[TBL] [Abstract][Full Text] [Related]
30. Humoral immune response to parvovirus B19 and serological diagnosis of B19 infection.
Manaresi E; Gallinella G; Gentilomi G; Venturoli S; Zuffi E; Bonvicini F; Cricca M; Zerbini M; Musiani M
Clin Lab; 2002; 48(3-4):201-5. PubMed ID: 11934222
[No Abstract] [Full Text] [Related]
31. [Parvovirus B19 infection after renal transplantation].
Rerolle JP; Helal I; Morelon E
Nephrologie; 2003; 24(6):309-15. PubMed ID: 14584298
[TBL] [Abstract][Full Text] [Related]
32. Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implications for pathogenesis doubtful.
Searle K; Schalasta G; Enders G
J Med Virol; 1998 Nov; 56(3):192-8. PubMed ID: 9783684
[TBL] [Abstract][Full Text] [Related]
33. Testing for parvovirus B19 in Henoch-Schönlein syndrome?
Riavis M; Vonlanthen R; Bianchetti MG
Pediatr Dermatol; 1998; 15(1):71. PubMed ID: 9496814
[No Abstract] [Full Text] [Related]
34. Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection.
Kerr JR; Cunniffe VS
Rheumatology (Oxford); 2000 Aug; 39(8):903-8. PubMed ID: 10952747
[TBL] [Abstract][Full Text] [Related]
35. [Rheumatologic manifestations of parvovirus B19 infection].
Chaabouni L; Amira C; Abdelmoula L; Ben Had YC; Kchir MM; Zouari R
Tunis Med; 2004 Jul; 82(7):642-7. PubMed ID: 15552021
[TBL] [Abstract][Full Text] [Related]
36. Possible transmission of parvovirus B19 from intravenous immune globulin.
Erdman DD; Anderson BC; Török TJ; Finkel TH; Anderson LJ
J Med Virol; 1997 Nov; 53(3):233-6. PubMed ID: 9365888
[TBL] [Abstract][Full Text] [Related]
37. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.
Gigler A; Dorsch S; Hemauer A; Williams C; Kim S; Young NS; Zolla-Pazner S; Wolf H; Gorny MK; Modrow S
J Virol; 1999 Mar; 73(3):1974-9. PubMed ID: 9971777
[TBL] [Abstract][Full Text] [Related]
38. B19 chronic bone marrow failure: a persistent parvovirus infection of humans.
Morinet F; Perol Y
Nouv Rev Fr Hematol (1978); 1990; 32(1):91-4. PubMed ID: 2161513
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus B19 infection and acute lymphoblastic leukaemia.
Savaşan S; Ozdemir O
Br J Haematol; 2003 Jan; 120(1):168-9. PubMed ID: 12492595
[No Abstract] [Full Text] [Related]
40. [Human parvovirus B19].
Ishii KK; Sasaki T
Nihon Rinsho; 2003 Mar; 61 Suppl 3():608-14. PubMed ID: 12718036
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
